MDM2 and breast carcinoma: A previous study showed that a common feature of RRS1 knockdown is an increase in the nucleoplasmic accumulation of RPL11.21 We predicted that ribosome‐free RPL11 and MDM2 would be involved in breast cancer proliferation inhibition upon RRS1 knockdown.